A Study of CLR325 in Chronic Stable Heart Failure Patients.

Clinical trial NCT02696967 · COMPLETED

Trial details

NCT number: NCT02696967
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Stable Heart Failure

Start date: 2016-05-17
Primary completion: 2019-01-14
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.